NCT00400205 - Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Squamous Cell CarcinomaOral Cancer

Interventions

DRUG

Docetaxel

Docetaxel 75 mg/m2, intravenous infusion over 1 hour, mixed with normal saline per institutional standard, day 1 and then every 3 weeks.

DRUG

Cisplatin

Cisplatin 100 mg/m2, intravenous infusion over 30 minutes to 3 hours, day 1 and then every 3 weeks.

DRUG

5-fluorouracil

5-fluorouracil 1000 mg/m2/day, 24 hour continuous infusion over 4 days, every 3 weeks.

Trial Locations (1)

Emory University Winship Cancer Institute, Atlanta